Search

EHA-SWG Scientific Meeting on Shaping the Future of Mesenchymal Stromal Cells Therapy

The EHA-SWG Scientific Meeting on Shaping the Future of Mesenchymal Stromal Cells Therapy brought together basic science, as well as translational and clinical research on November 23-25, 2017 in Amsterdam, The Netherlands.

Read more

Adding elotuzumab to standard treatment for multiple myeloma significantly reduced the risk of disease progression, with benefits sustained at two years

ELOQUENT-2, which evaluated elotuzumab in combination with lenalidomide and dexamethasone, is the first Phase III study to demonstrate the benefit of directly activating the immune system in the treatment of patients with relapsed or refractory multiple myeloma.

Read more

EHA attends the EuNet-INNOCHRON Final Conference

The EuNet-INNOCHRON Final Conference, a significant event in the field of hematology, took place in Chania, Crete, Greece from April 4-6, 2024.

Read more

EHA Statement on the Erasmus MC Attack

EHA is deeply saddened and appalled by the news of the twin shootings in Rotterdam, the Netherlands. We condemn these senseless acts of violence in the strongest possible terms.

Read more

EHA-SWG Scientific Meeting on Shaping the Future of Mesenchymal Stromal Cells Therapy

Dates: November 23-25, 2017
Location: Amsterdam, The Netherlands
Chair: WE Fibbe, F Dazzi

Organized by:

EHA and the EHA Scientific Working Group on Mesenchymal Stromal Cells

The SWG Meeting “Shaping the future of MSC therapy” brought together basic science, as well as translational and clinical research.…

Read more

EHA Exam

The 8th European Hematology Exam took place on June 13, 2024. The main exam session was held during the EHA2024 Hybrid Congress in Madrid, Spain. In total, 244 candidates took the exam at 15 locations.

Read more

Celebrating the International Day of Women & Girls in Science

On this International Day of Women & Girls in Science, we take a moment to honor, appreciate and thank, all the women scientists at the forefront of the fight against COVID-19.

Read more